臨床研究センター

先端医療技術開発研究室

2014年 国際学会・国内学会・研究会 発表

国際学会

American Heart Association Scientific Sessions Nov 16-19, 2014, Chicago, Illinois, USA

  • Takashi Unoki, Hiromichi Wada, Masaharu Akao, Shuichi Ura, Akira Yamada, Kensuke Takabayashi, Yugo Yamashita, Yasuhiro Hamatani, Nobutoyo Masunaga, Mitsuru Ishii, Moritake Iguchi, Hisashi Ogawa, Daisuke Takagi, Noriko Satoh-Asahara, Akira Shimatsu, and Koji Hasegawa.
    Serum Vascular Endothelial Growth Factor-C Levels are Inversely Associated with the Risk of Cardiac and Cerebrovascular Events Following Drug-eluting Stent Implantation.
    (Abstract 13044, Circulation. 2014; 130: A13044.)
  • Nobutoyo Masunaga, Hiromichi Wada, Masaharu Akao, Shuichi Ura, Akira Yamada, Mitsuru Abe, Mitsuru Ishii, Takashi Unoki, Moritake iguchi, Yugo Yamashita, Yasuhuro Hamatani, Hisashi Ogawa, Daisuke Takagi, Noriko Satoh-Asahara, Akira Shimatu, and Koji Hasegawa
    Serum Vascular Endothelial Growth Factor-C Levels are Inversely Associated With Major Adverse Cardiovascular Events in Patients With Arteriosclerotic Obliterans.
    (Abstract 12898, Circulation 2014; 130: A12898.)
  • Shuichi Ura, Hiromichi Wada, Noriko Satoh-Asahara, Masaharu Akao, Mitsuru Abe, Koh Ono, Tatsuya Morimoto, Akira Shimatsu, Yuko Takahashi, and Koji Hasegawa.
    Self-rating Depression Scale Score as an Inverse and Independent Predictor of Successful Smoking Cessation with a Pharmacological Treatment for Nicotine Addiction.
    (Abstract 17177, Circulation 2014; 130: A17177.)
  • Yasuhiro Hamatani, Hisashi Ogawa, Moritake Iguchi, Yugo Yamashita, Masahiro Esato, Yeong-Hwa Chun, Hiromichi Wada, Koji Hasegawa, Mitsuru Abe, and Masaharu Akao.
    Low Body Weight is Significantly Associated with the Incidence of Stroke in Atrial Fibrillation Patients.
    (Abstract 13236, Circulation. 2014; 130: A13236.)
  • Moritake Iguchi, Hisashi Ogawa, Nobutoyo Masunaga, Mitsuru Ishii, Masahiro Esato, Yeong-Hwa Chun, Hiromichi Wada, Koji Hasegawa, Mitsuru Abe, and Masaharu Akao.
    Validation of a Risk Score for Hospitalization for Heart Failure in Atrial Fibrillation Patients: From the Fushimi Af Registry.
    (Abstract 13205, Circulation. 2014;130:A13205.)
  • Kensuke Takabayashi, Yasuhiro Hamatani, Mitsuru Ishii, Hisashi Ogawa, Masahiro Esato, Yeong-Hwa Chun, Hiromichi Wada, Koji Hasegawa, Mitsuru Abe, and Masaharu Akao.
    Incidence of Stroke or Systemic Embolism in Paroxysmal versus Sustained Atrial Fibrillation: From the Fushimi Af Registry.
    (Abstract 12814, Circulation. 2014; 130: A12814.)
  • Hisashi Ogawa, Kensuke Takabayashi, Takashi Unoki, Mitsuru Ishii, Masahiro Esato, Yeong-Hwa Chun, Hiromichi Wada, Koji Hasegawa, Mitsuru Abe, and Masaharu Akao.
    Digitalis is not Associated with Increased Mortality in Japanese Patients with Atrial Fibrillation: From the Fushimi AF Registry.
  • Hisashi Ogawa, Kensuke Takabayashi, Takashi Unoki, Mitsuru Ishii, Masahiro Esato, Yeong-Hwa Chun, Hiromichi Wada, Koji Hasegawa, Mitsuru Abe, and Masaharu Akao.
    Female Gender is not a Risk of Various Adverse Events in Japanese Patients with Atrial Fibrillation: From the Fushimi AF Registry.
  • Yoichi Sunagawa, Miho Suzuki, Masafumi Funamoto, Yasufumi Katanasaka, Hidetoshi Suzuki, Akira Murakami, Hiromichi Wada, Atsushi Imaizumi, Tadashi Hashimoto, Akira Shimatsu, Takeshi Kimura, Masatoshi Fujita, Koji Hasegawa, and Tatsuya Morimoto.
    Auraptene, a Coumaric Compounds Analogous, Improved the Worsening of Systolic Function by Activating Mitochondrial Function After Myocardial Infarction in Rats.
    (Abstract 11983, Circulation. 2014; 130: A11983.)
  • Hidetoshi Suzuki, Yoichi Sunagawa, Yasufumi Katanasaka, Hiromichi Wada, Koji Hasegawa, and Tatsuya Morimoto.
    Receptor for Activated Protein Kinase C1 Competes With GATA4 for p300 and Represses Hypertrophic Responses in Cardiomyocyte.
    (Abstract 12566, Circulation. 2014; 130: A12566.)

European Society of Cardiology Congress 2014 Aug 30 - 03 Sep 4 Barcelona Spain

  • Wada H, Ura S, Masunaga N, Akao M, Ishii M, Unoki T, Abe M, Ono K, Morimoto T, Hasegawa K.
    Serum levels of soluble Flt-1 are associated with cardiovascular events in patients with chronic kidney disease (Abstract No. P1309, Program p101)
  • Ishii M, Wada H, Akao M, Ura S, Unoki T, Masunaga N, Iguchi M, Abe M, Satoh-Asahara N, Hasegawa K.
    The alpha1-antitrypsin/LDL complex level is associated with the SYNTAX score of complexity and severity of coronary artery disease (Abstract No. P1313, Program p101)
  • Masunaga N, Ogawa H, Ishii M, Unoki T, Esato M, Chun Y, Wada H, Hasegawa K, Abe M, Akao M.
    One-year oucomes of Japanese atrial fibrillation patients with vascular disease: From the Fushimi AF Registry (Abstract No. P797, Program p67)
  • Ogawa H, Yamashita Y, Unoki T, Masunaga N, Esato M, Chun Y, Wada H, Hasegawa K, Abe M, Akao M.
    Anti-arrhythmic drugs did not reduce progression from paroxysmal to sustained atrial fibrillation: From the Fushimi AF Registry (Abstract No. P1481, Program p109)
  • Hamatani Y, Takagi D, Iguchi M, Ogawa H, Esato M, Chun Y, Wada H, Hasegawa K, Abe M, Akao M.
    The relationship between left atrial enlargement and incidence of stroke in patients with atrial fibrillation: From the Fushimi AF Registry (Abstract No. P1580, Program p114)
  • Yamashita Y, Takagi D, Hamatani Y, Takabayashi K, Esato M, Chun Y, Wada H, Hasegawa K, Abe M, Akao M.
    Stroke and bleeding in super-elderly patients with atrial fibrillation: From one-year follow-up of the Fushimi AF Registry (Abstract No. 2251, Program p155)
  • Takabayashi K, Yamashita Y, Ogawa H, Masunaga N, Esato M, Chun Y, Wada H, Hasegawa K, Abe M, Akao M.
    Incidence of hospitalization for heart failure in patients with paroxysmal and sustained type of atrial fibrillation: One-year follow-up of the Fushimi AF Registry (Abstract No. 2468, Program p166)
  • Unoki T, Takabayashi K, Yamashita Y, Hamatani Y, Esato M, Chun Y, Wada H, Hasegawa K, Abe M, Akao M.
    Clinical characteristics and one-year outcomes of atrial fibrillation patients under rate- or rhythm-control strategy: From the Fushimi AF Registry (Abstract No. 2482, Program p167)
  • Esato M, Chun Y, Hashimoto T, Abe M, Tsuji H, Wada H, Hasegawa K, Akao M.
    Baseline characteristics and clinical outcomes of patients with atrial fibrillation undergoing catheter ablation: from the Fushimi AF Registry (Abstract No. 2484, Program p167)
  • Ogawa H, Takabayashi K, Unoki T, Ishii M, Esato M, Chun Y, Wada H, Hasegawa K, Abe M, Akao M.
    Female gender may not be a risk of stroke in Japanese patients with atrial fibrillation: from the Fushimi AF Registry (Abstract No. 2935, Program p193)
  • Komiyama M, Wada H, Yamakage H, Asahara-Satoh N, Shimada S, Shimatsu A, Koyama H, Kono K, Takahashi Y, Hasegawa K.
    The effect of weight gain after smoking cessation on atherogenic alpha1-antitrypsin0low-density lipoprotein (Abstract No. P3183, Program p209)
  • Abe M, Ogawa H, Masunaga N, Iguchi M, Ishii M, Esato M, Chun Y, Wada H, Hasegawa K, Akao M.
    Stroke or systemic embolism in atrial fibrillation with renal insufficiency: from the Fushimi AF Registry (Abstract No. P3224, Program p211)
  • Yamashita Y, Takagi D, Hamatani Y, Takabayashi K, Esato M, Chun Y, Wada H, Hasegawa K, Abe M, Akao M.
    Clinical characteristics and one-year outcomes of atrial fibrillation patients with versus without a previous stroke: From one-year follow-up of the Fushimi AF Registry (Abstract No. P4551, Program p286)
  • Takabayashi K, Takagi D, Hamatani Y, Unoki T, Esato M, Chun Y, Wada H, Hasegawa K, Abe M, Akao M.
    Incidence of hospitalization for heart failure in atrial fibrillation patients with anemia: one-year follow-up of the Fushimi AF Registry (Abstract No. P4683, Program p293)
  • Hamatani Y, Takabayashi K, Masunaga N, Ogawa H, Esato M, Chun Y, Wada H, Hasegawa K, Abe M, Akao M.
    The relationship between left atrial enlargement and incidence of heart failure in patients with non-valvular atrial fibrillation: From the Fushimi AF Registry (Abstract No. P4685, Program p293)
  • Masunaga N, Ogawa H, Iguchi M, Takabayashi K, Esato M, Chun Y, Wada H, Hasegawa K, Abe M, Akao M.
    The clinical characteristics and the risk of bleeding in atrial fibrillation patients receiving anti-platelet drugs: One-year follow-up of the Fushimi AF Registry (Abstract No. P5558, Program p345)
  • Ishii M, Ogawa H, Masunaga N, Iguchi M, Esato M, Chun Y, Wada H, Hasegawa K, Abe M, Akao M.
    Diabetes mellitus may not be a risk of stroke in Japanese patients with atrial fibrillation: From the Fushimi AF Registry (Abstract No. P5714, Program p354)
  • Takagi D, Yamashita Y, Hamatani Y, Takabayashi K, Esato M, Chun Y, Wada H, Hasegawa K, Abe M, Akao M.
    Clinical characteristics of young atrial fibrillation patients: From one-year follow-up of the Fushimi AF Registry (Abstract No. P6123, Program p379)

The 18th International Vascular Biology Meeting Apr 14-17, 2014, Kyoto, Japan

  • Hiromichi Wada, Kensuke Takabayashi, Masaharu Akao, Suichi Ura, Takashi Unoki, Yugo Yamashita, Yasuhiro Hamatani, Nobutoyo Masunaga, Mitsuru Ishii, Mitsuru Abe, Moritake Iguchi, Hisashi Ogawa, Noriko Satoh-Asahara, Akira Shimatsu, Koji Hasegawa
    Correlation between Serum Levels of Placental Growth Factor and Cardiovascular Events Following Coronary Drug-eluting Stent Implantation (P-498)
  • Takashi Unoki, Hiromichi Wada, Masaharu Akao, Suichi Ura, Nobutoyo Masunaga, Mitsuru Ishii, Mitsuru Abe, Moritake Iguchi, Kensuke Takabayashi, Hisashi Ogawa, Noriko Satoh-Asahara, Akira Shimatsu, Koji Hasegawa
    Inverse Correlation between Serum VEGF-C Levels and Severity of Coronary Artery Disease (P-059)

国内学会

第9回日本禁煙科学会学術集会福岡2014年10月25,26日

  • 浦 修一, 和田 啓道, 浅原 哲子, 赤尾 昌治, 尾野 亘, 森本 達也 島津 章, 高橋 裕子, 長谷川 浩二
    うつの指標SDSスコアは禁煙成功の負の独立規定因子のひとつである

第62回日本心臓病学会学術集会 2014年9月26-28日仙台

  • 石井 充,和田 啓道,赤尾 昌治,小谷 和彦,鵜木 崇,浦 修一山田 明,益永 信豊,阿部 充,井口 守丈,小川 尚,山下 侑吾,濱谷 康弘,浅原 哲子,長谷川 浩二
    α 1-antitrypsin/LDL 複合体はSYNTAX スコアと正の相関を示す (O-433)
  • 嶋田 清香,長谷川 浩二,和田 啓道,寺嶋 幸子,小見山 麻紀,浅原 哲子, 山陰 一,赤尾 昌治,飯田 夕子,島津 章,高橋 裕子
    禁煙による血液流動性の変化について (O-172)
  • 高木 大輔,鵜木 崇,益永 信豊,石井 充,小川 尚,井口 守丈,山下 侑吾,濱谷 康弘,和田 啓道,長谷川 浩二,阿部 充,赤尾 昌治
    当院における院外心停止患者に対するE-CPR と神経学的予後に関する検討 (O-140)
  • 喜田 孝史,岸本 周子,河合 実,北村 良雄,和田 啓道,井口 守丈,阿部 充, 小川 向,赤尾 昌治,長谷川 浩二,中尾 元紀
    アピキサバン投与前後の凝固指標評価の有用性に関する検討 (P-448)

第117回日本循環器学会近畿地方会 2014年7月12日 大阪

  • 濱谷 康弘, 小川 尚, 阿部 充, 鵜木 崇, 高木 大輔, 山下 侑吾, 石井 充, 井口 守丈, 益永 信豊, 中島 康代, 赤尾 昌治(循環器内科) 和田 啓道, 長谷川 浩二 (臨床研究センター)
    全身性エリテマトーデス,抗リン脂質抗体症候群に合併した冠動脈疾患の一例(B-28)
  • 山下 侑吾, 井口 守丈, 高木 大輔, 濱谷 康弘, 高林 健介, 鵜木 崇, 石井 充, 小川 尚, 益永 信豊, 中島 康代, 阿部 充, 赤尾 昌治(循環器内科) 和田 啓道, 長谷川 浩二 (臨床研究センター)
    甲状腺クリーゼに対して短時間作用型β遮断薬が有効であった一例 (C-26)
  • 高木 大輔, 小川 尚, 濱谷 康弘, 山下 侑吾, 高林 健介, 鵜木 崇, 石井 充, 井口 守丈, 益永 信豊, 中島 康代, 阿部 充, 赤尾 昌治 (循環器内科) 中村 道三 (神経内科) 和田 啓道, 長谷川 浩二 (臨床研究センター)
    低左心機能による心原性脳梗塞を来したと考えられる拡張型心筋症の一例 (C-32)
  • 小川 尚, 高橋 昌弘, 高木 大輔, 濱谷 康弘, 山下 侑吾, 高林 健介, 鵜木 崇, 石井 充, 井口 守丈, 益永 信豊, 中島 康代, 阿部 充, 赤尾 昌治 (循環器内科) 和田 啓道, 長谷川 浩二 (臨床研究センター) 後藤 貢士 (京大病院) 
    Lower common pathway を伴ったleft variant type AVNRT に対しカテーテルアブレーションを行った一例 (D-18)

第46回日本動脈硬化学会 2014年7月10-11日 東京

  • 和田 啓道, 高林 健介, 赤尾 昌治, 鵜木 崇, 浦 修一, 益永 信豊, 石井 充, 阿部 充, 井口 守丈, 山下 侑吾, 濱谷 康弘, 浅原 哲子, 長谷川 浩二
    冠動脈薬剤溶出性ステント留置後の心脳血管イベントと血清胎盤由来増殖因子レベルの関連 (演題番号1-P-47)

第51回日本臨床分子医学会学術集会 2014年04月11-12日 東京

  • 井口 守丈、和田 啓道、赤尾 昌治、浦 修一、益永 信豊、小川 尚、石井 充、鵜木 崇、高林 健介、濱谷 康弘、山下 侑吾、高木 大輔、阿部 充、島津 章、長谷川 浩二
    可溶性血管内皮成長因子受容体2は慢性心不全患者の予後予測因子となる (P-4)

第78回日本循環器学会学術集会 2014年03月21-23日東京

  1. Hiromichi Wada, Shuichi Ura, Nobutoyo Masunaga, Masaharu Akao, Mitsuru Ishii, Takashi Unoki, Mitsuru Abe, Ko Ono, Tatsuya Morimoto, Noriko Asahara, Akira Shimatsu, Koji Hasegawa
    Soluble Vascular Endothelial Growth Factor Receptor-1 Serves as a Predictor of Cardiovascular Events in Chronic Kidney Disease (FRS-081)
  2. Kensuke Takabayashi, Hiromichi Wada, Masaharu Akao, Takashi Unoki, Shuichi Ura, Mitsuru Abe, Nobutoyo Masunaga, Mitsuru Ishii, Yugo Yamashita, Yasuhiro Hamatani, Daisuke Takagi, Moritake Iguchi, Hisashi Ogawa, Noriko Asahara, Akira Shimatsu, Koji Hasegawa
    Placental Growth Factor as a Predictor of Cardiac and Cerebrovascular Events Following Elective Coronary Drug-eluting Stent Implantation (FRS-038)
  3. Moritake Iguchi, Hiromichi Wada, Masaharu Akao, Shuichi Ura, Nobutoyo Masunaga, Mitsuru Ishii, Takashi Unoki, Mitsuru Abe, Kensuke Takabayashi, Hisashi Ogawa, Shun-ichiro Niki, Yugo Yamashita, Yasuhiro Hamatani, Daisuke Takagi, Akira Shimatsu, Koji Hasegawa
    Prognostic Value of Soluble Vascular Endothelial Growth Factor Receptor-2 in Patients with Chronic Heart Failure (OE-109)
  4. Nobutoyo Masunaga, Hiromichi Wada, Masaharu Akao, Shuichi Ura, Mitsuru Ishii, Takashi Unoki, Moritake Iguchi, Mitsuru Abe, Kensuke Takabayashi, Yugo Yamashita, Yasuhiro Hamatani, Daisuke Takagi, Hisashi Ogawa, Noriko Asahara, Akira Shimatsu, Koji Hasegawa
    Vascular Endothelial Growth Factor-C Levels are Inversely Associated with the Severity of Arteriosclerotic Obliterans and the Risk of Cardiovascular Events (OE-239)
  5. Takashi Unoki, Hiromichi Wada, Masaharu Akao, Shuichi Ura, Kensuke Takabayashi, Yugo Yamashita, Yasuhiro Hamatani, Nobutoyo Masunaga, Mitsuru Ishii, Mitsuru Abe, Moritake Iguchi, Hisashi Ogawa, Daisuke Takagi, Noriko Asahara, Akira Shimatsu, Koji Hasegawa
    Low Vascular Endothelial Growth Factor-C Levels as a Risk Marker of Revascularization and Cardiac- and Cerebrovascular-events after Drug-eluting Stent Implantation (OE-386)
  6. Shuichi Ura, Hiromichi Wada, Noriko Asahara, Masaharu Akao, Ko Ono, Tatsuya Morimoto, Akira Shimatsu, Yuko Takahashi, Koji Haseegawa
    Self-rating Dpression Scale Score as an Independent Predictor of Unsuccessful Smoking Cessation (OJ-040)
  7. Mitsuru Ishii, Hiromichi Wada, Masaharu Akao, Shuichi Ura, Takashi Unoki, Nobutoyo Masunaga, Mitsuru Abe, Hisashi Ogawa, Moritake Iguchi, Kensuke Takabayashi, Yugo Yamashita, Yasuhiro Hamatani, Daisuke Takagi, Noriko Asahara, Akira Shimatsu, Koji Hasegawa
    The α 1-antitrypsin/LDL Complex Level is Associated with the SYNTAX Score of Complexity and Severity of Coronary Artery Disease (PE-674)
  8. Koji Hasegawa, Hiromichi Wada, Yuko Takahashi
    Blood Fluidity Assessed by the Micro-channel Method Sensitively Reflects Cardiovascular Risk in Smoking Patients (SY20-5)
  9. Masaharu Akao, Nobutoyo Masunaga, Hisashi Ogawa, Mitsuru Abe, Masahiro Esato, Tetsuo Hashimoto, Yeong-hwa Chun, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa
    Current Status of Anti-thrombotic Therapy for Patients with Atrial Fibrillation in Japan: Insights from the Fushimi AF Registry (SY10-2)
  10. Mitsuru Abe, Masahiro Esato, Yeong-hwa Chun, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Masaharu Akao
    Stroke or Systemic Embolism in Atrial Fibrillation with Renal Insufficiency: From the Fushimi AF Registry (FRS-085)
  11. Nobutoyo Masunaga, Hisashi Ogawa, Mitsuru Ishii, Mitsuru Abe, Masahiro Esato, Yeong-hwa Chun, Hikari Tsuji, HiromichiWada, Koji Hasegawa,,Masaharu Akao
    The Risk of Bleeding in Atrial Fibrillation Patients Prescribed Multiple Anti-platelet Drugs: From One-year Follow-up of the Fushimi AF Registry (FRS-117)
  12. Yugo Yamashita, Yasuhiro Hamatani, Kensuke Takabayashi, Mitsuru Abe, Masahiro Esato, Yeong-hwa Chun, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Masaharu Akao
    Stroke and Bleeding Events in Super-elderly Patients with Atrial Fibrillation: From One-year Follow-up of the Fushimi AF Registry (OE-082)
  13. Hisashi Ogawa, Takashi Unoki, Mitsuru Ishii, Mitsuru Abe, Masahiro Esato, Yeong-hwa Chun, Hikari Tsuji, HiromichiWada, Koji Hasegawa, Masaharu Akao
    Female Gender may not be a Risk of Stroke in Japanese Patients with Atrial Fibrillation: From the Fushimi AF Registry (OE-086)
  14. Hisashi Ogawa, Yugo Yamashita, Nobutoyo Masunaga, Mitsuru Abe, Masahiro Esato, Yeong-hwa Chun, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Masaharu Akao
    Rhythm-control Therapy did not Reduce Progression from Paroxysmal to Sustained Atrial Fibrillation: From the Fushimi AF Registry (OE-087)
  15. Kensuke Takabayashi, Takashi Unoki, Hisashi Ogawa, Mitsuru Abe, Masahiro Esato, Yeong-hwa Chun, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Masaharu Akao
    Incidence of Stroke in Patients with Paroxysmal and Sustained Type of Atrial Fibrillation: One year Follow-up of the Fushimi AF Registry (OE-088)
  16. Nobutoyo Masunaga, Hisashi Ogawa, Mitsuru Ishii, Mitsuru Abe, Masahiro Esato, Yeong-hwa Chun, Hikari Tsuji, HiromichiWada, Koji Hasegawa, Masaharu Akao
    Effect of Vascular Disease on the Incidence of Stroke in Japanese Atrial Fibrillation Patients: From the Fushimi AF Registry (OJ-098)
  17. Takashi Unoki, Kensuke Takabayashi, Yugo Yamashita, Yasuhiro Hamatani, Mitsuru Abe, Masahiro Esato, Yeong-hwa Chun, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Masaharu Akao
    Clinical Characteristics and One-year Outcome of Atrial Fibrillation Patients under Rate- or Rhythm-control Strategy: From the Fushimi AF Registry (OJ-104)
  18. Mitsuru Ishii, Mitsuru Abe, Hisashi Ogawa, Nobutoyo Masunaga, Moritake Iguchi, Masahiro Esato, Yeong-hwa Chun, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Masaharu Akao
    Diabetes Mellitus may not be a Risk of Stroke in Japanese Patients with Atrial Fibrillation: From the Fushimi AF Registry (PE-184)
  19. Yasuhiro Hamatani Hisashi Ogawa, Yugo Yamashita, Kensuke Takabayashi, Mitsuru Abe, Masahiro Esato, Yeong-hwa Chun, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Masaharu Akao
    The Relationship between Left Atrial Enlargement and Incidence of Stroke in Patients with Atrial Fibrillation: From the Fushimi AF Registry (PE-194)
  20. Yasuhiro Hamatani, Hisashi Ogawa, Yugo Yamashita, Kensuke Takabayashi, Mitsuru Abe, Masahiro Esato, Yeong-hwa Chun, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Masaharu Akao
    Clinical Characteristics of Atrial Fibrillation Patients with Low Body Weight: From the Fushimi AF Registry (PE-363)
  21. Masahiro Esato, Yeong-hwa Chun, Tetsuo Hashimoto, Mitsuru Abe, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Masaharu Akao
    Baseline Characteristics and Clinical Outcomes of Patients with Atrial Fibrillation Undergoing Catheter Ablation: From the Fushimi AF Registry (PE-565)
  22. Hisashi Ogawa, Yasuhiro Hamatani, Moritake Iguchi, Mitsuru Abe, Masahiro Esato, Yeong-hwa Chun, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Masaharu Akao
    Left Atrial Diameter as a Predictor of Progression from Paroxysmal to Sustained Atrial Fibrillation: From the Fushimi AF Registry (PJ-112)
  23. Daisuke Takagi, Yasuhiro Hamatani, Yugo Yamashita, Kensuke Takabayashi, Mitsuru Abe, Masahiro Esato, Yeong-hwa Chun, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Masaharu Akao
    Clinical Characteristics and One-year Outcome of Young Patients with Atrial Fibrillation: From the Fushimi AF Registry (PJ-420)
  24. Moritake Iguchi, Hisashi Ogawa, Mitsuru Abe, Masahiro Esato, Yeong-hwa Chun, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Masaharu Akao
    The Relationship between Systolic Dysfunction and Incidence of Stroke in Patients with Atrial Fibrillation: From the Fushimi AF Registry (PJ-525)
  25. Hikari Tsuji, Koji Terada, Kayoko Furukawa, Yoko Taniguchi, Mitsuru Abe, Masahiro Esato, Yeong-hwa Chun, Hiromichi Wada, Koji Hasegawa, Masaharu Akao
    Clinical Characteristics of Atrial Fibrillation Patients between Private Clinics and Cardiovascular Centers: One-year Follow-up of the Fushimi AF Registry (PJ-603)
  26. Hidetoshi Suzuki, Yoichi Sunagawa, Yasufumi Katanasaka, Toshiki Tanaka, Hiromichi Wada, Akira Shimatsu, Masatoshi Fujita, Koji Hasegawa, Tatsuya Morimoto
    Receptor for Activated Protein Kinase C1, a Novel Component of p300/GATA4 Complex, Repress Hypertrophic Responses in Cultured Cardiomyocytes (OE-117)
  27. Yoichi Sunagawa, Yasufumi Katanasaka, Hidetoshi Suzuki, Naruto Hajika, Hiromichi Wada, Akira Shimatsu, Masatoshi Fujita, Koji Hasegawa, Tatsuya Morimoto
    MEK-1-dependent Phosphorylation of GATA4 Relieves Repressor Function of Novel GATA4 Binding Proteins, RbAp48/46, during Cardiomyocyte Hypertrophy (OE-351)
  28. Yasufumi Katanasaka, Sae Hirano, Yoichi Sunagawa, Hidetoshi Suzuki, Hiromichi Wada, Akira Shimatsu, Koji Hasegawa, Tatsuya Morimoto
    Cardiac Myocyte Hypertrophy and Fibrosis in vitro are Inhibited by Lipophilic Pitavastatin but not by Hydrophilic Rosuvastatin (PJ-182)
  29. Takahito Osanai, Yasufumi Katanasaka, Masatoshi Namiki, Yoichi Sunagawa, Hiromichi Wada, Hidetoshi Suzuki, Akira Shimatsu, Koji Hasegawa, Tatsuya Morimoto
    Transducin Beta-like Protein 1/Histone Deacetylase 3 Complex Suppresses Hypertrophyresponsive Gene Transcription by Inhibiting p300/GATA4 Pathway in Cardiomyocytes (PJ-329)

研究会

平成26年度 臨床研究部講演会 平成26年6月27日 愛媛医療センター

  • 和田 啓道
    「心血管疾患とリスクファクター」(講演)

→先端医療技術開発研究室 (心血管リスクとバイオマーカー研究グループ)

電話番号0756419161 救命救急|24時間365日対応

アクセス
アクセス